Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FCUV✓SelectedUSD · FCUVGSK vs FCUV performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs FCUV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+89.7%
FCUV return
-96.6%
Excess return
+186.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioFCUVExcessAlpha
1D-1.3%-1.7%+0.4%-1.3%
7D-3.1%+47.5%-50.7%-3.1%
30D-0.9%+26.8%-27.7%-0.9%
3M-4.2%-42.3%+38.1%-4.2%
6M-1.6%+31.4%-33.0%-1.5%
YTD+2.6%-86.1%+88.7%+2.7%
1Y+6.2%-95.5%+101.8%+6.3%
3Y+55.0%-99.3%+154.3%+55.2%
5Y+42.8%-99.8%+142.6%+43.1%
10Y+102.1%-98.9%+201.0%+103.4%
All+89.7%-96.6%+186.4%+95.0%

Cumulative growth

Daily Returns

Daily percentage return beside FCUV.

Daily Out/Under-Performance

Portfolio return minus FCUV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FCUV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded FCUV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling